The Heineken Prize is among the most prestigious in the scientific community, and a recognition of lifetime achievement which is widely regarded as second only to a Nobel Prize. The award recognises Professor Dobson's achievements in helping to identify the root causes of so-called “modern” disorders, such as Alzheimer’s and Parkinson’s diseases.
New sequencing technology is transforming epigenetics research, and could greatly improve understanding of cancer, embryo formation, stem cells and brain function.
Although anti-HIV drugs can significantly prolong life, patients must take the drugs for the rest of their lives. New approaches to therapeutics may hold the answer to finding a cure for HIV.
An extension to the University of Cambridge’s exchange programme with the Massachusetts Institute of Technology has been announced, enabling more undergraduates to study at “both” Cambridges during their degree.
The researchers are recognised for 'the excellence of their work and the profound implications their findings have had for others'.
Research will explore using sunlight to convert greenhouse gas carbon dioxide and water to syngas, the precursor to liquid fuel.
A new, single-step method of fabricating microcapsules, which have potential commercial applications in industries including medicine, agriculture and diagnostics, has been developed by researchers at the University of Cambridge. The findings are published Friday (10 February) in the journal Science.
Research is bringing closer the conversion of simple organic molecules into drugs, plastics or potential new fuels in a single step.
A new phase of research harnessing materials for rechargeable batteries is beginning in the Department of Chemistry.
The path from innovation to impact can be long and complex. Here we describe the fascinating story behind the development of a new type of electronic reader.
© 2025 University of Cambridge